BeStock  
Markets › Compare › JANX vs AVLN

JANX vs AVLN

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
JANX · Janux Therapeutics$17.92 ▲ 6.73%
AVLN · Avalyn Pharma$25.53 ▲ 0.39%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8398114129144Apr 30, '26Jul 21, '26Oct 7, '26
  • JANX +24.7%
  • AVLN -13.4%

Head to head

MetricJANXAVLN
Price$17.92$25.53
Change today▲ 6.73%▲ 0.39%
Market cap$1.10B$1.13B
Return, 3 months+7.0%-11.7%
Return, year to date+29.9%–
Return, 1 year-26.0%–
P/E (TTM)-10.9-11.0
P/B1.22.8
P/E percentile vs own 5y46th95th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)+35.1%-43.3%
Gross margin––
Operating margin-598.1%–
Net margin-427.5%–
Return on equity-10.7%-25.9%
Analyst target vs. price+91.0%+120.6%
Analyst buy share91%100%
RSI (14)5631
30-day volatility52.8%55.6%
Max drawdown, 1 year-64.9%-35.2%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AVLN is the largest of the group by market value.
  • AVLN carries the lowest trailing P/E.
  • JANX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top